Regeneron Pharmaceuticals Inc at Jefferies Virtual London Healthcare Conference Transcript
Welcome, everyone, to the Jefferies London Virtual Health Care Conference. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to welcome Regeneron and their Chief Financial Officer, Robert Landry; as well as Head of Investor Relations, Justin Holko. So before -- this will be a fireside chat format. So before we get started with the Q&A, I believe you have forward-looking statements that you'd like to read, and then maybe we can get started. But welcome, Bob and Justin, and thanks for attending our conference.
Sure, Biren. Thanks very much for the invite. This is a conference we've been at the last couple of years and have always enjoyed attending that. And to everyone on the virtual environment, good morning and good afternoon to everybody.
So as Biren said before we begin, let me remind you that today, there will be remarks on this webcast,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
